Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?

BACKGROUND: The management of COVID-19 in organ transplant recipients is among the most imperative, yet less discussed, issues based on their immunocompromised status along with their vast post-transplant medication regimens. No conclusive study has been published to evaluate proper anti-viral and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafiekhani, Mojtaba, Shahabinezhad, Farbod, Niknam, Tahmoores, Tara, Seyed Ahmad, Haem, Elham, Mardani, Parviz, Zare, Zahra, Jafarian, Sedigheh, Mirzad Jahromi, Khatereh, Arabsheybani, Sara, Moeini, Yalda Sadat, Alavi, Jalile, Jalali, Seyed Soroush, Salimi, Maryam, Shahriarirad, Reza, Malekhosseini, Seyed Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607221/
https://www.ncbi.nlm.nih.gov/pubmed/34809657
http://dx.doi.org/10.1186/s12985-021-01700-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607221/
https://www.ncbi.nlm.nih.gov/pubmed/34809657
http://dx.doi.org/10.1186/s12985-021-01700-2

Ejemplares similares